Navigation Links
ECT WS2000

ProductsECT WS2000
Company CARDIOLINE
Item ECT WS2000
Features 
  • ECT 12 Transmitter
  • Leads: 12 leads, acquired simultaneously and continuously
  • Filters: drift filter, muscle tremor filters
  • Transmission: saturation by infrared beams
  • Power Supply: 1 alkaline battery, 9 V
  • Size & Weight: 90 x 155 x 35 mm; 250 gr (battery included)}
  • Data acquisition: 12 bit A/D, 500 Hz
  • ST parametrs: STj, STj+x (x selectable and variable in real time), slope, area
  • Arrhythmias: classification and trend of the main arrhythmias
  • Selectable alarms: maximum HR, arrhythmias and ST events
    • Description ECT WS 2000 is designed to monitor, store and measure data during the performance of cardiovascular provocative tests, (stress-testing). The system can organize the amount of information detected during the test and provide them for a quick review and printout of an extremely flexible final report.

    The recorded ECG is transmitted via a small portable ECG recorder (ECT 12 no bigger than a recorder for ambulatory ECG monitoring) powered by a 9 V alkaline battery. The ECG signal is acquired via standard disposable electrodes. ECT 12 is applied around the patients waist with a belt. Signal reception is delivered wirelessly, via infrared, by a small dome equipped with photo detectors and connected to a receiving demodulation post analysis card, connected to the unit.

    The system ECT WS 2000 receives the 12 ECG leads in real time, it checks and monitors the operation of a cycloergometer and/or treadmill; it receives commands and/or data from an alphanumeric keyboard; it displays the ECG trace and measurements on a high resolution digital monitor and, lastly, it manages a high performance thermal printer for real time or full disclosure printouts (full disclosure for one or more leads, tables, arrhythmias, measurements, averaging, graphs, trends, etc.).
    Info CARDIOLINE
    Customer Service: (800) 942-0442

    Related medicine products :

    1. Quest Diagnostics
    2. The Quest ACTester Activated Clotting Time System
    3. 100 Questions in Cardiology
    4. ExTOL Exercise Stress Systems
    5. CASE 8000 Cardiac Assessment System for Exercise
    6. X-Scribe II Stress Exercise System
    7. PCE-110 PC-Based Exercise Stress System
    8. PCE-210 PC-Based Exercise Stress System
    9. StressVue Exercise Stress Testing System
    10. Tango Exercise Stress BP Monitor
    11. Burdick HeartStride Exercise Stress System
    TAG: ECT
    mobileMICROMEDEX™ gives physicians, pharmacists, and other healthcare professionals reliable clinical information to help support and confirm treatment decisions. Clinicians can trust the data i
    Focuses primarily on the drugs used for treatment and symptom management for colorectal cancer.
    Portable Drug Companion is a comprehensive, authoritative drug reference to chose from over 5,500 entries, with overdose management, Canadian drug names, OTC and herbal remedies. This "Mini-Suite" of
    The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy.
    Medicine Products:
    (Date:12/3/2008)...enchmark data providing information by disease sta...s , , SAN FRANCISCO, Dec. 3 /PRNewswire-USN...or and effectiveness of their health and productiv... Benefits Institute (IBI) announced today the avai...oes IBI,s benchmarking offer the ability to access...
    (Date:12/3/2008)...) treatment seems to improve cognitive functioning...fer from obstructive sleep apnea, according to the...at the University of California, San Diego. The st...of psychiatry at the UC San Diego School of Medici...he field of sleep disorders and sleep research in ...
    (Date:12/3/2008)...ian television viewers will get,a chance to learn...ht when the,documentary "The Brain That Changes I...n network. Based on the best-selling book of the ...ntary traces the development of the,science of ne..., products and,customers of Posit Science Corpora...
    (Date:12/3/2008)...rvice Reductions , , WASHINGTON, Dec. 3 /P...or Quality Respiratory Care (CQRC) -- an alliance ... manufacturers that care for nearly half of Medica...eparing for massive Medicare cuts to the program,s... , , The Medicare Part B home oxygen bene...
    Breaking Medicine News(10 mins):Health News:Integrated Benefits Institute Announces Availability of 2007 IBI Benchmarking Data for Employers to Evaluate Effectiveness of their Health and Productivity Programs 2Health News:Treating sleep apnea in Alzheimer's patients helps cognition 2Health News:Treating sleep apnea in Alzheimer's patients helps cognition 3Health News:Posit Science Featured in Canadian Documentary on the Brain 2Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 2Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 3
    ...ewborns could be in the risk category for childhoo...rs from France, Italy and Germany have published//...of Cancer, indicating that the number of cases of ... from 120 cases per million in 1978 to 140 in 1997...
    ... been diagnosed in about 2.5 million Americans of ...g side effects from epilepsy medications. // Howev...ry and are often at high risk for complications. ...ted in the brain itself offer hope for an effectiv...
    ...don’t realize that the foot and leg pain, which th...or simply due to increase in age, could actually b... // People especially, diabetics could be at a ri...t and leg pain. Around 20.8 million people suffer ...
    ...ngiogenic drug is successfully starving a cancer p... cells circulating in the individual’s bloodstream...marker for gauging the medication’s effectiveness,...e (NCI) research. Previous studies have shown that...
    Other Medicine News:Health News:Epilepsy Treated with Implanted Devices 2Health News:Limb amputations among Diabetics on a high 2Health News:Limb amputations among Diabetics on a high 3Health News:Potential Diagnostic Marker Indicates Effectiveness of Anti-Angiogenic Drugs 2Health News:Potential Diagnostic Marker Indicates Effectiveness of Anti-Angiogenic Drugs 3
    (Date:12/3/2008)...wire-FirstCall/ -- Wyeth Pharmaceuticals,a divis...it has submitted a,marketing authorization applic...A) for approval to market its investigational 13-v...infants and young children. Wyeth is seeking an,...ase (PD) caused by the 13,serotypes included in t...
    (Date:12/2/2008)...swire/ -- Researchers using functional,MRI (fMRI)... the brain,responsible for suppressing memory is ...elated psychiatric disorders. Results of the study... the Radiological Society of North America,(RSNA)... other stress-related disorders,traumatic memori...
    (Date:12/2/2008)... -- Horizon Therapeutics, Inc., a,privately held ...o pivotal,Phase 3 trials evaluating its lead inve...rimary endpoints. HZT-501, a novel, proprietary fi... and famotidine, demonstrated a,statistically sig...al,anti-inflammatory drug (NSAID)-induced upper g...
    (Date:12/1/2008)... TargeGen has announced that an oral,presentation...ased clinical,trial of TG101348 in myeloprolifera...008 American Society of Hematology (ASH) Meeting. ...ows:, Title: A Phase I Study of... JAK2-Selective Inhibitor, in Patients wit...
    Breaking Medicine Technology:Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Beauty for Life 3A The Future of Cosmetic Medicine 18275 1Beauty for Life 3A The Future of Cosmetic Medicine 18275 2Beauty for Life 3A The Future of Cosmetic Medicine 18275 3Hear Indiana Announces Talk Walk Run 2008 18272 1Hear Indiana Announces Talk Walk Run 2008 18272 2Hear Indiana Announces Talk Walk Run 2008 18272 3USDA Grants Organic Certification to Ayalas Herbal Water 28TM 29 18269 1USDA Grants Organic Certification to Ayalas Herbal Water 28TM 29 18269 2GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 5070 1GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 5070 2GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 5070 3
    ...lar Ultrasound Demonstrates Utility in Evaluating ...ous Potential for HDL,Therapy , ,PLEASANTON, CA, M...-- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. Brya...Sciences, Inc., concluded from,the wide range of p...diology (ACC) Meeting in New Orleans that the rati...
    ...D Awareness Month: Time to Pay Attention to this,O...007 /PRNewswire/ -- During,National Sexually Trans...ission Pharmacal is urging increased awareness of,...rich"), the most,common curable STD in the United ...spite the fact that trich affects an estimated 7.4...
    Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 2Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million,Annually 3